For many patients undergoing a treatment program, improvements can be sustained when the condition is suitable and the recommended activity advice and rehabilitation plan are followed
On the Fast Track to treat sleep apnea There is limited research on the effectiveness of weight loss medications for sleep apnea, but the landscape is rapidly changing
For weight management (NICE TA875 for semaglutide 2.4mg/Wegovy and TA664 for liraglutide 3mg/Saxenda): Treatment should be discontinued if specific weight loss targets are not met (typically at least 5% of initial body weight at 12-16 weeks)
Limit high-fat foods : Limit creamy sauces and soups, and choose baked or grilled rather than fried foods
The peptide, made from human gastric juice, is not approved for clinical use in any country (13)
Semaglutide has shown significant benefits in managing blood sugar levels by stimulating insulin secretion and reducing glucose production in the liver